Glycyl-L-proline transport in rabbit enterocyte basolateral-membrane vesicles.
The properties of a peptide-transport system in rabbit enterocyte basolateral membrane were examined with glycyl-L-proline as the substrate. Basolateral-membrane vesicles prepared from rabbit proximal intestine were characterized in terms of both purity and orientation. Marker-enzyme assays show that the basolateral-membrane marker, ouabain-sensitive K(+)-activated phosphatase, is enriched 17-fold with respect to the initial homogenate. The activities of enzymes used as markers for other membranes and organelles are low, and contamination of the final membrane fraction with these is minimal. The use of immunoblotting techniques further confirms the absence of brush-border-membrane contamination. Proteins in the basolateral-membrane vesicle preparation gave no cross-reaction with antibodies against the 140 kDa antigen and the Na+/glucose-symport protein, markers specific to the brush-border membrane of the enterocyte. Conversely, antibodies raised against the classical basolateral-membrane marker, the RLA class I histocompatibility complex, reacted strongly with a 43 kDa basolateral-membrane protein. The orientation of the basolateral-membrane vesicles was shown to be predominantly inside-out on determination by two independent criteria. The uptake of [1-14C]glycyl-L-proline by these vesicles is stimulated by the presence of an inwardly directed pH gradient, and this stimulation can be abolished by the proton ionophores carbonyl cyanide p-trichloromethoxyphenylhydrazone (CCCP) and tetrachlorotrifluoromethylbenzimidazole (TTFB). Transport is also inhibited by HgCl2, thimerosal, Na+ and other glycyl dipeptides.
Dyer
J
J
Department of Biochemistry, University College of Wales, Aberystwyth, U.K.
Beechey
R B
RB
Gorvel
J P
JP
Smith
R T
RT
Wootton
R
R
Shirazi-Beechey
S P
SP
D000596:Amino Acids / Q000494:pharmacology; D000818:Animals; D001692:Biological Transport; D003851:Deoxyribonucleases / Q000378:metabolism; D004151:Dipeptides / Q000493:pharmacokinetics* / Q000494:pharmacology; D004789:Enzyme Activation; D005947:Glucose / Q000378:metabolism; D007413:Intestinal Mucosa / Q000378:metabolism*; D007422:Intestines / Q000166:cytology / Q000648:ultrastructure; D007425:Intracellular Membranes / Q000378:metabolism*; D007700:Kinetics; D008565:Membrane Proteins / Q000276:immunology; D008871:Microvilli / Q000276:immunology / Q000648:ultrastructure; D009994:Osmolar Concentration; D010042:Ouabain / Q000494:pharmacology; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism; D011188:Potassium / Q000494:pharmacology; D011817:Rabbits
D000596:Amino Acids; D004151:Dipeptides; D008565:Membrane Proteins; D010042:Ouabain; C015248:glycylproline; D003851:Deoxyribonucleases; D010744:Phosphoric Monoester Hydrolases; D005947:Glucose; D011188:Potassium